Aquestive Therapeutics
AQST
AQST
97 hedge funds and large institutions have $177M invested in Aquestive Therapeutics in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
+40
Holders Change %
+70.18%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
51
Increased
23
Reduced
14
Closed
9
Calls
$4.24M
Puts
$1.97M
Net Calls
+$2.27M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
VA
VR Adviser
New York
|
+$23.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$9.46M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$6.58M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.77M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.26M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$7.93M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$994K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$584K |
| 4 |
Two Sigma Investments
New York
|
-$479K |
| 5 |
Corient Private Wealth
Miami,
Florida
|
-$408K |
